메뉴 건너뛰기




Volumn 70, Issue 2, 2007, Pages 163-170

Immunogenicity of infliximab: How to handle the problem?

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIBODY; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CORTICOSTEROID; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PARACETAMOL; PROMETHAZINE;

EID: 34447519227     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (42)

References (4)
  • 1
    • 3042579454 scopus 로고    scopus 로고
    • Incidence and importance of antibody responses to infliximab after maintenance of episodic treatment in Crohn's disease
    • HANAUER S., WAGNER C., BALA M. et al. Incidence and importance of antibody responses to infliximab after maintenance of episodic treatment in Crohn's disease. Clin. Gastroenterol. Hepatol., 2004, 2 : 542-553.
    • (2004) Clin. Gastroenterol. Hepatol , vol.2 , pp. 542-553
    • HANAUER, S.1    WAGNER, C.2    BALA, M.3
  • 3
    • 10744221312 scopus 로고    scopus 로고
    • Infliximab maintenance therapy for fistulizing Crohn's disease
    • SANDS B.E., ANDERSON F.H., BERNSTEIN C.N. et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N. Engl. J. Med., 2004, 350 : 876-85.
    • (2004) N. Engl. J. Med , vol.350 , pp. 876-885
    • SANDS, B.E.1    ANDERSON, F.H.2    BERNSTEIN, C.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.